Global Parkinson’s Disease Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Parkinson’s Disease Therapeutics market size was valued at USD 2405.4 million in 2023 and is forecast to a readjusted size of USD 3558 million by 2030 with a CAGR of 5.8% during review period.
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The market for Parkinson's disease therapeutics is driven by the increasing prevalence of Parkinson's disease and the demand for symptomatic relief and disease-modifying treatments. The market's growth is also influenced by ongoing research in Parkinson's disease pathophysiology and the development of novel therapeutic approaches.
The Global Info Research report includes an overview of the development of the Parkinson’s Disease Therapeutics industry chain, the market status of Hospitals (Oral, Transdermal), Clinics (Oral, Transdermal), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parkinson’s Disease Therapeutics.
Regionally, the report analyzes the Parkinson’s Disease Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parkinson’s Disease Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parkinson’s Disease Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parkinson’s Disease Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Transdermal).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parkinson’s Disease Therapeutics market.
Regional Analysis: The report involves examining the Parkinson’s Disease Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parkinson’s Disease Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parkinson’s Disease Therapeutics:
Company Analysis: Report covers individual Parkinson’s Disease Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parkinson’s Disease Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Parkinson’s Disease Therapeutics. It assesses the current state, advancements, and potential future developments in Parkinson’s Disease Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parkinson’s Disease Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parkinson’s Disease Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Parkinson’s Disease Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parkinson’s Disease Therapeutics, with revenue, gross margin and global market share of Parkinson’s Disease Therapeutics from 2019 to 2024.
Chapter 3, the Parkinson’s Disease Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Parkinson’s Disease Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson’s Disease Therapeutics.
Chapter 13, to describe Parkinson’s Disease Therapeutics research findings and conclusion.
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The market for Parkinson's disease therapeutics is driven by the increasing prevalence of Parkinson's disease and the demand for symptomatic relief and disease-modifying treatments. The market's growth is also influenced by ongoing research in Parkinson's disease pathophysiology and the development of novel therapeutic approaches.
The Global Info Research report includes an overview of the development of the Parkinson’s Disease Therapeutics industry chain, the market status of Hospitals (Oral, Transdermal), Clinics (Oral, Transdermal), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Parkinson’s Disease Therapeutics.
Regionally, the report analyzes the Parkinson’s Disease Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Parkinson’s Disease Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Parkinson’s Disease Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Parkinson’s Disease Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Transdermal).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Parkinson’s Disease Therapeutics market.
Regional Analysis: The report involves examining the Parkinson’s Disease Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Parkinson’s Disease Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Parkinson’s Disease Therapeutics:
Company Analysis: Report covers individual Parkinson’s Disease Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Parkinson’s Disease Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Parkinson’s Disease Therapeutics. It assesses the current state, advancements, and potential future developments in Parkinson’s Disease Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Parkinson’s Disease Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Parkinson’s Disease Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Oral
- Transdermal
- Subcutaneous
- Intestinal Infusion
- Hospitals
- Clinics
- Others
- Abbvie
- Biogen
- Boehringer Ingelheim GmbH
- F. Hoffman-La Roche
- GlaxoSmithKline
- H. Lundbeck A/S
- Impax Labs
- Newron Pharmaceuticals SpA
- Novartis AG
- Orion Corporation
- Teva Pharmaceutical Industries Ltd.
- UCB S.A.
- Livzon Pharmaceutical
- Haisco Pharmaceutical
- Jingxin Pharmaceutical
- Dongcheng Biochemicals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Parkinson’s Disease Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Parkinson’s Disease Therapeutics, with revenue, gross margin and global market share of Parkinson’s Disease Therapeutics from 2019 to 2024.
Chapter 3, the Parkinson’s Disease Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Parkinson’s Disease Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson’s Disease Therapeutics.
Chapter 13, to describe Parkinson’s Disease Therapeutics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Parkinson’s Disease Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Parkinson’s Disease Therapeutics by Type
1.3.1 Overview: Global Parkinson’s Disease Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Oral
1.3.4 Transdermal
1.3.5 Subcutaneous
1.3.6 Intestinal Infusion
1.4 Global Parkinson’s Disease Therapeutics Market by Application
1.4.1 Overview: Global Parkinson’s Disease Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Parkinson’s Disease Therapeutics Market Size & Forecast
1.6 Global Parkinson’s Disease Therapeutics Market Size and Forecast by Region
1.6.1 Global Parkinson’s Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Parkinson’s Disease Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business
2.1.3 Abbvie Parkinson’s Disease Therapeutics Product and Solutions
2.1.4 Abbvie Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbvie Recent Developments and Future Plans
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business
2.2.3 Biogen Parkinson’s Disease Therapeutics Product and Solutions
2.2.4 Biogen Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biogen Recent Developments and Future Plans
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business
2.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product and Solutions
2.3.4 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.4 F. Hoffman-La Roche
2.4.1 F. Hoffman-La Roche Details
2.4.2 F. Hoffman-La Roche Major Business
2.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product and Solutions
2.4.4 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hoffman-La Roche Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Product and Solutions
2.5.4 GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 H. Lundbeck A/S
2.6.1 H. Lundbeck A/S Details
2.6.2 H. Lundbeck A/S Major Business
2.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product and Solutions
2.6.4 H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 H. Lundbeck A/S Recent Developments and Future Plans
2.7 Impax Labs
2.7.1 Impax Labs Details
2.7.2 Impax Labs Major Business
2.7.3 Impax Labs Parkinson’s Disease Therapeutics Product and Solutions
2.7.4 Impax Labs Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Impax Labs Recent Developments and Future Plans
2.8 Newron Pharmaceuticals SpA
2.8.1 Newron Pharmaceuticals SpA Details
2.8.2 Newron Pharmaceuticals SpA Major Business
2.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product and Solutions
2.8.4 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Newron Pharmaceuticals SpA Recent Developments and Future Plans
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Parkinson’s Disease Therapeutics Product and Solutions
2.9.4 Novartis AG Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novartis AG Recent Developments and Future Plans
2.10 Orion Corporation
2.10.1 Orion Corporation Details
2.10.2 Orion Corporation Major Business
2.10.3 Orion Corporation Parkinson’s Disease Therapeutics Product and Solutions
2.10.4 Orion Corporation Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Orion Corporation Recent Developments and Future Plans
2.11 Teva Pharmaceutical Industries Ltd.
2.11.1 Teva Pharmaceutical Industries Ltd. Details
2.11.2 Teva Pharmaceutical Industries Ltd. Major Business
2.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product and Solutions
2.11.4 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.12 UCB S.A.
2.12.1 UCB S.A. Details
2.12.2 UCB S.A. Major Business
2.12.3 UCB S.A. Parkinson’s Disease Therapeutics Product and Solutions
2.12.4 UCB S.A. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 UCB S.A. Recent Developments and Future Plans
2.13 Livzon Pharmaceutical
2.13.1 Livzon Pharmaceutical Details
2.13.2 Livzon Pharmaceutical Major Business
2.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
2.13.4 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Livzon Pharmaceutical Recent Developments and Future Plans
2.14 Haisco Pharmaceutical
2.14.1 Haisco Pharmaceutical Details
2.14.2 Haisco Pharmaceutical Major Business
2.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
2.14.4 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Haisco Pharmaceutical Recent Developments and Future Plans
2.15 Jingxin Pharmaceutical
2.15.1 Jingxin Pharmaceutical Details
2.15.2 Jingxin Pharmaceutical Major Business
2.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
2.15.4 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Jingxin Pharmaceutical Recent Developments and Future Plans
2.16 Dongcheng Biochemicals
2.16.1 Dongcheng Biochemicals Details
2.16.2 Dongcheng Biochemicals Major Business
2.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product and Solutions
2.16.4 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Dongcheng Biochemicals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Parkinson’s Disease Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Parkinson’s Disease Therapeutics by Company Revenue
3.2.2 Top 3 Parkinson’s Disease Therapeutics Players Market Share in 2023
3.2.3 Top 6 Parkinson’s Disease Therapeutics Players Market Share in 2023
3.3 Parkinson’s Disease Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Parkinson’s Disease Therapeutics Market: Region Footprint
3.3.2 Parkinson’s Disease Therapeutics Market: Company Product Type Footprint
3.3.3 Parkinson’s Disease Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Parkinson’s Disease Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Parkinson’s Disease Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Parkinson’s Disease Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Parkinson’s Disease Therapeutics Market Size by Country
6.3.1 North America Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Parkinson’s Disease Therapeutics Market Size by Country
7.3.1 Europe Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region
8.3.1 Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Parkinson’s Disease Therapeutics Market Size by Country
9.3.1 South America Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country
10.3.1 Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Parkinson’s Disease Therapeutics Market Drivers
11.2 Parkinson’s Disease Therapeutics Market Restraints
11.3 Parkinson’s Disease Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Parkinson’s Disease Therapeutics Industry Chain
12.2 Parkinson’s Disease Therapeutics Upstream Analysis
12.3 Parkinson’s Disease Therapeutics Midstream Analysis
12.4 Parkinson’s Disease Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Parkinson’s Disease Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Parkinson’s Disease Therapeutics by Type
1.3.1 Overview: Global Parkinson’s Disease Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Oral
1.3.4 Transdermal
1.3.5 Subcutaneous
1.3.6 Intestinal Infusion
1.4 Global Parkinson’s Disease Therapeutics Market by Application
1.4.1 Overview: Global Parkinson’s Disease Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Parkinson’s Disease Therapeutics Market Size & Forecast
1.6 Global Parkinson’s Disease Therapeutics Market Size and Forecast by Region
1.6.1 Global Parkinson’s Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Parkinson’s Disease Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Parkinson’s Disease Therapeutics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business
2.1.3 Abbvie Parkinson’s Disease Therapeutics Product and Solutions
2.1.4 Abbvie Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbvie Recent Developments and Future Plans
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business
2.2.3 Biogen Parkinson’s Disease Therapeutics Product and Solutions
2.2.4 Biogen Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biogen Recent Developments and Future Plans
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business
2.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product and Solutions
2.3.4 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.4 F. Hoffman-La Roche
2.4.1 F. Hoffman-La Roche Details
2.4.2 F. Hoffman-La Roche Major Business
2.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product and Solutions
2.4.4 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 F. Hoffman-La Roche Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Product and Solutions
2.5.4 GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 H. Lundbeck A/S
2.6.1 H. Lundbeck A/S Details
2.6.2 H. Lundbeck A/S Major Business
2.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product and Solutions
2.6.4 H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 H. Lundbeck A/S Recent Developments and Future Plans
2.7 Impax Labs
2.7.1 Impax Labs Details
2.7.2 Impax Labs Major Business
2.7.3 Impax Labs Parkinson’s Disease Therapeutics Product and Solutions
2.7.4 Impax Labs Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Impax Labs Recent Developments and Future Plans
2.8 Newron Pharmaceuticals SpA
2.8.1 Newron Pharmaceuticals SpA Details
2.8.2 Newron Pharmaceuticals SpA Major Business
2.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product and Solutions
2.8.4 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Newron Pharmaceuticals SpA Recent Developments and Future Plans
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Parkinson’s Disease Therapeutics Product and Solutions
2.9.4 Novartis AG Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novartis AG Recent Developments and Future Plans
2.10 Orion Corporation
2.10.1 Orion Corporation Details
2.10.2 Orion Corporation Major Business
2.10.3 Orion Corporation Parkinson’s Disease Therapeutics Product and Solutions
2.10.4 Orion Corporation Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Orion Corporation Recent Developments and Future Plans
2.11 Teva Pharmaceutical Industries Ltd.
2.11.1 Teva Pharmaceutical Industries Ltd. Details
2.11.2 Teva Pharmaceutical Industries Ltd. Major Business
2.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product and Solutions
2.11.4 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.12 UCB S.A.
2.12.1 UCB S.A. Details
2.12.2 UCB S.A. Major Business
2.12.3 UCB S.A. Parkinson’s Disease Therapeutics Product and Solutions
2.12.4 UCB S.A. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 UCB S.A. Recent Developments and Future Plans
2.13 Livzon Pharmaceutical
2.13.1 Livzon Pharmaceutical Details
2.13.2 Livzon Pharmaceutical Major Business
2.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
2.13.4 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Livzon Pharmaceutical Recent Developments and Future Plans
2.14 Haisco Pharmaceutical
2.14.1 Haisco Pharmaceutical Details
2.14.2 Haisco Pharmaceutical Major Business
2.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
2.14.4 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Haisco Pharmaceutical Recent Developments and Future Plans
2.15 Jingxin Pharmaceutical
2.15.1 Jingxin Pharmaceutical Details
2.15.2 Jingxin Pharmaceutical Major Business
2.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
2.15.4 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Jingxin Pharmaceutical Recent Developments and Future Plans
2.16 Dongcheng Biochemicals
2.16.1 Dongcheng Biochemicals Details
2.16.2 Dongcheng Biochemicals Major Business
2.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product and Solutions
2.16.4 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Dongcheng Biochemicals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Parkinson’s Disease Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Parkinson’s Disease Therapeutics by Company Revenue
3.2.2 Top 3 Parkinson’s Disease Therapeutics Players Market Share in 2023
3.2.3 Top 6 Parkinson’s Disease Therapeutics Players Market Share in 2023
3.3 Parkinson’s Disease Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Parkinson’s Disease Therapeutics Market: Region Footprint
3.3.2 Parkinson’s Disease Therapeutics Market: Company Product Type Footprint
3.3.3 Parkinson’s Disease Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Parkinson’s Disease Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Parkinson’s Disease Therapeutics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Parkinson’s Disease Therapeutics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Parkinson’s Disease Therapeutics Market Size by Country
6.3.1 North America Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Parkinson’s Disease Therapeutics Market Size by Country
7.3.1 Europe Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Parkinson’s Disease Therapeutics Market Size by Region
8.3.1 Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Parkinson’s Disease Therapeutics Market Size by Country
9.3.1 South America Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Country
10.3.1 Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Parkinson’s Disease Therapeutics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Parkinson’s Disease Therapeutics Market Drivers
11.2 Parkinson’s Disease Therapeutics Market Restraints
11.3 Parkinson’s Disease Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Parkinson’s Disease Therapeutics Industry Chain
12.2 Parkinson’s Disease Therapeutics Upstream Analysis
12.3 Parkinson’s Disease Therapeutics Midstream Analysis
12.4 Parkinson’s Disease Therapeutics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Parkinson’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parkinson’s Disease Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Parkinson’s Disease Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Parkinson’s Disease Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbvie Company Information, Head Office, and Major Competitors
Table 6. Abbvie Major Business
Table 7. Abbvie Parkinson’s Disease Therapeutics Product and Solutions
Table 8. Abbvie Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbvie Recent Developments and Future Plans
Table 10. Biogen Company Information, Head Office, and Major Competitors
Table 11. Biogen Major Business
Table 12. Biogen Parkinson’s Disease Therapeutics Product and Solutions
Table 13. Biogen Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Biogen Recent Developments and Future Plans
Table 15. Boehringer Ingelheim GmbH Company Information, Head Office, and Major Competitors
Table 16. Boehringer Ingelheim GmbH Major Business
Table 17. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product and Solutions
Table 18. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Table 20. F. Hoffman-La Roche Company Information, Head Office, and Major Competitors
Table 21. F. Hoffman-La Roche Major Business
Table 22. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product and Solutions
Table 23. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. F. Hoffman-La Roche Recent Developments and Future Plans
Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline Major Business
Table 27. GlaxoSmithKline Parkinson’s Disease Therapeutics Product and Solutions
Table 28. GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline Recent Developments and Future Plans
Table 30. H. Lundbeck A/S Company Information, Head Office, and Major Competitors
Table 31. H. Lundbeck A/S Major Business
Table 32. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product and Solutions
Table 33. H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. H. Lundbeck A/S Recent Developments and Future Plans
Table 35. Impax Labs Company Information, Head Office, and Major Competitors
Table 36. Impax Labs Major Business
Table 37. Impax Labs Parkinson’s Disease Therapeutics Product and Solutions
Table 38. Impax Labs Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Impax Labs Recent Developments and Future Plans
Table 40. Newron Pharmaceuticals SpA Company Information, Head Office, and Major Competitors
Table 41. Newron Pharmaceuticals SpA Major Business
Table 42. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product and Solutions
Table 43. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Newron Pharmaceuticals SpA Recent Developments and Future Plans
Table 45. Novartis AG Company Information, Head Office, and Major Competitors
Table 46. Novartis AG Major Business
Table 47. Novartis AG Parkinson’s Disease Therapeutics Product and Solutions
Table 48. Novartis AG Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Novartis AG Recent Developments and Future Plans
Table 50. Orion Corporation Company Information, Head Office, and Major Competitors
Table 51. Orion Corporation Major Business
Table 52. Orion Corporation Parkinson’s Disease Therapeutics Product and Solutions
Table 53. Orion Corporation Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Orion Corporation Recent Developments and Future Plans
Table 55. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 56. Teva Pharmaceutical Industries Ltd. Major Business
Table 57. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product and Solutions
Table 58. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 60. UCB S.A. Company Information, Head Office, and Major Competitors
Table 61. UCB S.A. Major Business
Table 62. UCB S.A. Parkinson’s Disease Therapeutics Product and Solutions
Table 63. UCB S.A. Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. UCB S.A. Recent Developments and Future Plans
Table 65. Livzon Pharmaceutical Company Information, Head Office, and Major Competitors
Table 66. Livzon Pharmaceutical Major Business
Table 67. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
Table 68. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Livzon Pharmaceutical Recent Developments and Future Plans
Table 70. Haisco Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. Haisco Pharmaceutical Major Business
Table 72. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
Table 73. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Haisco Pharmaceutical Recent Developments and Future Plans
Table 75. Jingxin Pharmaceutical Company Information, Head Office, and Major Competitors
Table 76. Jingxin Pharmaceutical Major Business
Table 77. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
Table 78. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Jingxin Pharmaceutical Recent Developments and Future Plans
Table 80. Dongcheng Biochemicals Company Information, Head Office, and Major Competitors
Table 81. Dongcheng Biochemicals Major Business
Table 82. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product and Solutions
Table 83. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Dongcheng Biochemicals Recent Developments and Future Plans
Table 85. Global Parkinson’s Disease Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 86. Global Parkinson’s Disease Therapeutics Revenue Share by Players (2019-2024)
Table 87. Breakdown of Parkinson’s Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Parkinson’s Disease Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Parkinson’s Disease Therapeutics Players
Table 90. Parkinson’s Disease Therapeutics Market: Company Product Type Footprint
Table 91. Parkinson’s Disease Therapeutics Market: Company Product Application Footprint
Table 92. Parkinson’s Disease Therapeutics New Market Entrants and Barriers to Market Entry
Table 93. Parkinson’s Disease Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Parkinson’s Disease Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Parkinson’s Disease Therapeutics Consumption Value Share by Type (2019-2024)
Table 96. Global Parkinson’s Disease Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 97. Global Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024)
Table 98. Global Parkinson’s Disease Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 99. North America Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Parkinson’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Parkinson’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Parkinson’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Parkinson’s Disease Therapeutics Raw Material
Table 130. Key Suppliers of Parkinson’s Disease Therapeutics Raw Materials
Table 1. Global Parkinson’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Parkinson’s Disease Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Parkinson’s Disease Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Parkinson’s Disease Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbvie Company Information, Head Office, and Major Competitors
Table 6. Abbvie Major Business
Table 7. Abbvie Parkinson’s Disease Therapeutics Product and Solutions
Table 8. Abbvie Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbvie Recent Developments and Future Plans
Table 10. Biogen Company Information, Head Office, and Major Competitors
Table 11. Biogen Major Business
Table 12. Biogen Parkinson’s Disease Therapeutics Product and Solutions
Table 13. Biogen Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Biogen Recent Developments and Future Plans
Table 15. Boehringer Ingelheim GmbH Company Information, Head Office, and Major Competitors
Table 16. Boehringer Ingelheim GmbH Major Business
Table 17. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product and Solutions
Table 18. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Table 20. F. Hoffman-La Roche Company Information, Head Office, and Major Competitors
Table 21. F. Hoffman-La Roche Major Business
Table 22. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product and Solutions
Table 23. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. F. Hoffman-La Roche Recent Developments and Future Plans
Table 25. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 26. GlaxoSmithKline Major Business
Table 27. GlaxoSmithKline Parkinson’s Disease Therapeutics Product and Solutions
Table 28. GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. GlaxoSmithKline Recent Developments and Future Plans
Table 30. H. Lundbeck A/S Company Information, Head Office, and Major Competitors
Table 31. H. Lundbeck A/S Major Business
Table 32. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product and Solutions
Table 33. H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. H. Lundbeck A/S Recent Developments and Future Plans
Table 35. Impax Labs Company Information, Head Office, and Major Competitors
Table 36. Impax Labs Major Business
Table 37. Impax Labs Parkinson’s Disease Therapeutics Product and Solutions
Table 38. Impax Labs Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Impax Labs Recent Developments and Future Plans
Table 40. Newron Pharmaceuticals SpA Company Information, Head Office, and Major Competitors
Table 41. Newron Pharmaceuticals SpA Major Business
Table 42. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product and Solutions
Table 43. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Newron Pharmaceuticals SpA Recent Developments and Future Plans
Table 45. Novartis AG Company Information, Head Office, and Major Competitors
Table 46. Novartis AG Major Business
Table 47. Novartis AG Parkinson’s Disease Therapeutics Product and Solutions
Table 48. Novartis AG Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Novartis AG Recent Developments and Future Plans
Table 50. Orion Corporation Company Information, Head Office, and Major Competitors
Table 51. Orion Corporation Major Business
Table 52. Orion Corporation Parkinson’s Disease Therapeutics Product and Solutions
Table 53. Orion Corporation Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Orion Corporation Recent Developments and Future Plans
Table 55. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 56. Teva Pharmaceutical Industries Ltd. Major Business
Table 57. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product and Solutions
Table 58. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 60. UCB S.A. Company Information, Head Office, and Major Competitors
Table 61. UCB S.A. Major Business
Table 62. UCB S.A. Parkinson’s Disease Therapeutics Product and Solutions
Table 63. UCB S.A. Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. UCB S.A. Recent Developments and Future Plans
Table 65. Livzon Pharmaceutical Company Information, Head Office, and Major Competitors
Table 66. Livzon Pharmaceutical Major Business
Table 67. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
Table 68. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Livzon Pharmaceutical Recent Developments and Future Plans
Table 70. Haisco Pharmaceutical Company Information, Head Office, and Major Competitors
Table 71. Haisco Pharmaceutical Major Business
Table 72. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
Table 73. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Haisco Pharmaceutical Recent Developments and Future Plans
Table 75. Jingxin Pharmaceutical Company Information, Head Office, and Major Competitors
Table 76. Jingxin Pharmaceutical Major Business
Table 77. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product and Solutions
Table 78. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Jingxin Pharmaceutical Recent Developments and Future Plans
Table 80. Dongcheng Biochemicals Company Information, Head Office, and Major Competitors
Table 81. Dongcheng Biochemicals Major Business
Table 82. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product and Solutions
Table 83. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Dongcheng Biochemicals Recent Developments and Future Plans
Table 85. Global Parkinson’s Disease Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 86. Global Parkinson’s Disease Therapeutics Revenue Share by Players (2019-2024)
Table 87. Breakdown of Parkinson’s Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Parkinson’s Disease Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Parkinson’s Disease Therapeutics Players
Table 90. Parkinson’s Disease Therapeutics Market: Company Product Type Footprint
Table 91. Parkinson’s Disease Therapeutics Market: Company Product Application Footprint
Table 92. Parkinson’s Disease Therapeutics New Market Entrants and Barriers to Market Entry
Table 93. Parkinson’s Disease Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Parkinson’s Disease Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Parkinson’s Disease Therapeutics Consumption Value Share by Type (2019-2024)
Table 96. Global Parkinson’s Disease Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 97. Global Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024)
Table 98. Global Parkinson’s Disease Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 99. North America Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Parkinson’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Parkinson’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Parkinson’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Parkinson’s Disease Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Parkinson’s Disease Therapeutics Raw Material
Table 130. Key Suppliers of Parkinson’s Disease Therapeutics Raw Materials
LIST OF FIGURES
Figure 1. Parkinson’s Disease Therapeutics Picture
Figure 2. Global Parkinson’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Oral
Figure 5. Transdermal
Figure 6. Subcutaneous
Figure 7. Intestinal Infusion
Figure 8. Global Parkinson’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Parkinson’s Disease Therapeutics Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Others Picture
Figure 13. Global Parkinson’s Disease Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Parkinson’s Disease Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Parkinson’s Disease Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Region in 2023
Figure 18. North America Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Parkinson’s Disease Therapeutics Revenue Share by Players in 2023
Figure 24. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Parkinson’s Disease Therapeutics Market Share in 2023
Figure 26. Global Top 6 Players Parkinson’s Disease Therapeutics Market Share in 2023
Figure 27. Global Parkinson’s Disease Therapeutics Consumption Value Share by Type (2019-2024)
Figure 28. Global Parkinson’s Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 29. Global Parkinson’s Disease Therapeutics Consumption Value Share by Application (2019-2024)
Figure 30. Global Parkinson’s Disease Therapeutics Market Share Forecast by Application (2025-2030)
Figure 31. North America Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Parkinson’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Parkinson’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. France Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 48. China Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. India Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Parkinson’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Parkinson’s Disease Therapeutics Market Drivers
Figure 66. Parkinson’s Disease Therapeutics Market Restraints
Figure 67. Parkinson’s Disease Therapeutics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Parkinson’s Disease Therapeutics in 2023
Figure 70. Manufacturing Process Analysis of Parkinson’s Disease Therapeutics
Figure 71. Parkinson’s Disease Therapeutics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Parkinson’s Disease Therapeutics Picture
Figure 2. Global Parkinson’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Oral
Figure 5. Transdermal
Figure 6. Subcutaneous
Figure 7. Intestinal Infusion
Figure 8. Global Parkinson’s Disease Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Parkinson’s Disease Therapeutics Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Others Picture
Figure 13. Global Parkinson’s Disease Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Parkinson’s Disease Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Parkinson’s Disease Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Parkinson’s Disease Therapeutics Consumption Value Market Share by Region in 2023
Figure 18. North America Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Parkinson’s Disease Therapeutics Revenue Share by Players in 2023
Figure 24. Parkinson’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Parkinson’s Disease Therapeutics Market Share in 2023
Figure 26. Global Top 6 Players Parkinson’s Disease Therapeutics Market Share in 2023
Figure 27. Global Parkinson’s Disease Therapeutics Consumption Value Share by Type (2019-2024)
Figure 28. Global Parkinson’s Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 29. Global Parkinson’s Disease Therapeutics Consumption Value Share by Application (2019-2024)
Figure 30. Global Parkinson’s Disease Therapeutics Market Share Forecast by Application (2025-2030)
Figure 31. North America Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Parkinson’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Parkinson’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 41. France Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Parkinson’s Disease Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 48. China Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 51. India Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Parkinson’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Parkinson’s Disease Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Parkinson’s Disease Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 65. Parkinson’s Disease Therapeutics Market Drivers
Figure 66. Parkinson’s Disease Therapeutics Market Restraints
Figure 67. Parkinson’s Disease Therapeutics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Parkinson’s Disease Therapeutics in 2023
Figure 70. Manufacturing Process Analysis of Parkinson’s Disease Therapeutics
Figure 71. Parkinson’s Disease Therapeutics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
